News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
March, 2025
March 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  
Rashid Sayyid: RW study of LuPSMA in VISION-eligible mCRPC patients
Photo from Rashid Sayyid/X
Jun 11, 2024, 22:40

Rashid Sayyid: RW study of LuPSMA in VISION-eligible mCRPC patients

Rashid Sayyid, Urologic Oncology Clinical Fellow at University of Toronto, shared a post on X:

“RW study of LuPSMA in VISION-eligible mCRPC patients from expanded access program (UCLA, UCSF, Tulane, Johns Hopkins; n=117) compared to VISION phase 3 results.

  • RW patients more likely to have received >1 ARPI (70% versus 46%), have worse PS, and have LN disease
  • Similar OS (15.1) and PSA50 (42%)
  • Increased incidence of Gr3+ lymphopenia in RW (34% versus 8%)

Results support use of LuPSMA in RW setting.”

Rashid Sayyid: RW study of LuPSMA in VISION-eligible mCRPC patients

Source: Rashid Sayyid/X

ARPI cancer Gr3+ lymphopenia Johns Hopkins LN disease LuPSMA mCRPC OncoDaily Oncology PSA50 Rashid Sayyid Research RW study Tulane UCLA UCSF vision
Special Coverage
Science
Mar 22, 2025, 09:11
Myeloma Paper of the Day, March 22nd, suggested by Robert Orlowski
Blog
Mar 22, 2025, 09:00
Andrea Anampa-Guzmán: Fantastic time at the ASCO AIOM Clinical Research Course
Blog
Mar 22, 2025, 08:43
Richard Sassun: It is time to give Tumor Deposit a proper role in the staging
Blog
Mar 22, 2025, 08:34
Registration open for the 8th "Combinations and Sequences in therapy" conference
Blog
Mar 22, 2025, 08:02
AstraZeneca announced plans to establish a new global strategic Research and Development center in Beijing
Science
Mar 22, 2025, 07:56
Leveraging Immunogenic Cell Death to Enhance the Immune Response against Malignant Pleural Mesothelioma Tumors - The Babak Lab
Blog
Mar 22, 2025, 07:49
UICC joined the Commonwealth Secretariat and the Lancet Oncology Commission in London
Blog
Mar 22, 2025, 07:42
President of Cairo University visited the Breast Cancer Hospital (NCI - New Cairo)
Blog
Mar 22, 2025, 07:31
Istvan Petak: We have officially launched BRECISE in Madrid
Science
Mar 22, 2025, 07:26
Elvina Almuradova: Cemiplimab monotherapy vs chemotherapy as a first-line treatment with advanced NSCLC with PD-L1 expression
Blog
Mar 22, 2025, 07:23
Reducing disparities in cancer prevention, screening, and access to treatment - SPCC
Science
Mar 22, 2025, 07:12
Jennifer Bires: Fertility Preservation in People with Cancer